Clinical Trials in Pittsburgh

Showing 7701-7720 of 21,047 trials

NeuraGen 3D Pilot Study

NCT05343143

This is a 10-subject, 12-month follow-up, prospective, multi-center, open-label, single arm clinical trial designed to understand the initial performance characteristics and confirm the safety profile of the NeuraGen 3D Nerve Guide Matrix.

Digital Nerve Injury

Integra LifeSciences Corporation1 participantsStarted May 2022

New York, New York, United States • Durham, North Carolina, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 3< 1 mile

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

NCT04657016

This is a study of tirzepatide in participants with obesity. The purpose of this study is to learn more about how tirzepatide maintains body weight or adds to weight loss after an intensive lifestyle modification program. The study will last about 2 years (29 visits).

ObesityOverweight

Eli Lilly and Company579 participantsStarted Mar 2021

Huntington Park, California, United States • Los Angeles, California, United States • Montclair, California, United States +62 more locations

NeuraGen 3D Pilot Study

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

Find Trials by Condition in Pittsburgh

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

PARTNER 3 Trial - Aortic Valve-in-Valve

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

A Post Market Study to Confirm the Safety and Performance of the Signia™ Stapling System.

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates

VIA Disc NP Registry

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

A Study of TAK-071 in People With Parkinson Disease

ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

Cigarette Pack Inserts for Smoking Cessation

Comparative Performance of a Vaginal Yeast Test

The Cognitive Ageing Nutrition and Neurogenesis (CANN) Trial

A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Processes in Healthy Adults

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis